SPIEGELMAN DANIEL K
SEC CIK 1238403 · EDGAR
BoughtSold
Most active insiders at KYTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Westlake BioPartners Opportunity Fund I, L.P. | 10% | $1000.0K | — |
| 2 | SEIDENBERG BETH C | Dir | $1000.0K | — |
| 3 | Walker Karen Marie | CTO | — | $292.8K |
| 4 | GEHCHAN NAJI | See Remarks | — | — |
| 5 | Aktar Mert | Dir | — | — |
| 6 | Biddle Warner Weston | CEO, Dir | — | — |
| 7 | Emany Sravan Kumar | Dir | — | — |
| 8 | Miller Andrew Craig | Dir | — | — |
| 9 | GRASSO MARC | CFO | — | — |
| 10 | Shaw Christi | Executive COB, Dir | — | — |
SPIEGELMAN DANIEL K made no open-market trades at KYTX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-02 | 2025-05-29 | KYTX | Kyverna Therapeutics, Inc. | SPIEGELMAN DANIEL K | Dir | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
| M | 2024-06-04 | 2024-06-03+ | MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Dir | S - Sale | $22.04 | -7,576 | 32.9K | -19% | -$167.0K |
| 2023-06-02 | 2023-06-01 | MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Dir | A - Grant | $0.00 | +15.2K | 49.1K | +45% | $0 | |
| 2023-06-02 | 2023-06-02 | MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Dir | S - Sale | $23.01 | -8,638 | 40.5K | -18% | -$198.8K | |
| 2022-06-06 | 2022-06-06 | MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Dir | S - Sale | $19.25 | -6,424 | 34.0K | -16% | -$123.7K | |
| 2022-06-03 | 2022-06-02 | MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Dir | A - Grant | $0.00 | +17.3K | 40.4K | +75% | $0 |
Purchase Sale Sale after option exercise All abbreviations